XML 49 R38.htm IDEA: XBRL DOCUMENT v3.25.1
Note 15 - Equity Incentive Plans (Tables)
9 Months Ended
Mar. 31, 2025
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
          

Weighted

 
          

Average

 
      

Weighted

  

Remaining

 
  

Number of

  

Average

  

Contractual

 
  

Options

  

Exercise Price

  

Life in Years

 

Outstanding at June 30, 2024

  146,539  $6.18   8.8 

Granted

  87,500  $1.83   9.6 

Forfeited/cancelled

  (11,906) $1.84    

Expired

  (2,889) $17.21    

Outstanding at March 31, 2025

  219,244  $4.53   8.3 
             

Exercisable at March 31, 2025

  93,425  $8.05   8.0 
Nonvested Restricted Stock Shares Activity [Table Text Block]
      

Weighted

 
      

Average Grant

 
  

Number of

  

Date Fair

 
  

Shares

  

Value

 

Unvested at June 30, 2024

  24,105  $100.34 

Granted

  20,000  $1.79 

Vested

  (9,577) $15.97 

Unvested at March 31, 2025

  34,528  $66.66 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
      

Weighted

 
      

Average Grant

 
  

Number of

  

Date Fair

 
  

Shares

  

Value

 

Unvested at June 30, 2024

  1,775  $24.14 

Vested

  (1,524) $24.47 

Forfeited

  (167) $26.20 

Unvested at March 31, 2025

  84  $21.20 
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
  

Three Months Ended

  

Nine Months Ended

 
  

March 31,

  

March 31,

 
  

2025

  

2024

  

2025

  

2024

 
  

(in thousands)

 

Cost of sales

 $  $  $1  $1 

Research and development

  8   2   11   5 

Selling and marketing

  11      57    

General and administrative

  120   697   394   2,125 

Net income (loss) from discontinued operations, net of tax

     112      430 

Total stock-based compensation expense

 $139  $811  $463  $2,561